Sales Slump Will Linger Beyond Recession's End - Nielsen
This article was originally published in The Tan Sheet
Executive Summary
The recession may be over "from a technical perspective," according to the Federal Reserve, but the global financial crisis likely will continue to negatively impact branded nonprescription drug sales in the next year, a recent Nielsen survey shows
You may also be interested in...
History Lesson: P&G Among Firms To Make Boldness Pay In Tight Economy
History seems to be on the side of consumer product companies that make bold marketing moves during economic slumps
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands